AU4474201A - Process for preparing optically active aminopentane derivatives - Google Patents

Process for preparing optically active aminopentane derivatives

Info

Publication number
AU4474201A
AU4474201A AU44742/01A AU4474201A AU4474201A AU 4474201 A AU4474201 A AU 4474201A AU 44742/01 A AU44742/01 A AU 44742/01A AU 4474201 A AU4474201 A AU 4474201A AU 4474201 A AU4474201 A AU 4474201A
Authority
AU
Australia
Prior art keywords
optically active
preparing optically
derivatives
active aminopentane
aminopentane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44742/01A
Inventor
Takahiro Oka
Mayumi Watanabe
Takuya Yasusa
Fumio Yoneda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujimoto Brothers Co Ltd
Original Assignee
Fujimoto Brothers Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Brothers Co Ltd filed Critical Fujimoto Brothers Co Ltd
Publication of AU4474201A publication Critical patent/AU4474201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU44742/01A 2000-04-11 2001-04-09 Process for preparing optically active aminopentane derivatives Abandoned AU4474201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-109622 2000-04-11
JP2000109622A JP4691230B2 (en) 2000-04-11 2000-04-11 Process for producing optically active 1- (benzofuran-2-yl) -2-propylaminopentane
PCT/JP2001/003057 WO2001077074A1 (en) 2000-04-11 2001-04-09 Process for preparing optically active aminopentane derivatives

Publications (1)

Publication Number Publication Date
AU4474201A true AU4474201A (en) 2001-10-23

Family

ID=18622288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44742/01A Abandoned AU4474201A (en) 2000-04-11 2001-04-09 Process for preparing optically active aminopentane derivatives

Country Status (3)

Country Link
JP (1) JP4691230B2 (en)
AU (1) AU4474201A (en)
WO (1) WO2001077074A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723102A2 (en) * 2004-03-11 2006-11-22 Elan Pharmaceuticals, Inc. N-substituted benzene sulfonamides
JP5030194B2 (en) 2004-11-25 2012-09-19 国立大学法人九州大学 Drug dependence treatment
AU2006263167C1 (en) * 2005-06-28 2012-06-21 Fujimoto Co., Ltd. Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate
JP5862949B2 (en) * 2012-02-15 2016-02-16 国立大学法人 名古屋工業大学 9-epiaminopicolinamide catalyst

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007667A1 (en) * 1997-08-07 1999-02-18 Fujimoto Brothers Co., Ltd. Novel ethylamine derivatives
JP4499208B2 (en) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション Novel optically active aminopentane derivatives

Also Published As

Publication number Publication date
JP4691230B2 (en) 2011-06-01
WO2001077074A1 (en) 2001-10-18
JP2001294583A (en) 2001-10-23

Similar Documents

Publication Publication Date Title
AU2001252588A1 (en) Method for preparing microsphere
AU1919900A (en) Process for preparing trifluoroarylaluminum etherates
AU2002230470A1 (en) Process for preparing pouches
AU2001295926A1 (en) Process for producign optically active ethyl
AU2003242072A1 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-METHYLCYSTEINE DERIVATIVE
HUP0105169A3 (en) Process for producing optically active pyridineethanol derivatives
AU5540900A (en) Novel method for preparing optically active alpha-aminonitriles
AU4474201A (en) Process for preparing optically active aminopentane derivatives
AU2002222604A1 (en) Process for preparing substance GM-95
AU2001255460A1 (en) Process for preparing lipid ii
AU6727700A (en) Process for the preparation of optically active sulfoxide derivatives
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU2001244657A1 (en) Process for producing optically active alpha-hydroxy-gamma-butyrolactone
AU3232701A (en) Processes for preparing optically active amino acid derivatives
AU2001278807A1 (en) Optically active aziridine-2-carboxylate derivatives and a process for preparingthem
AU5123300A (en) Process for preparing 10,11-methanobenzosuberane derivatives
AU2301099A (en) Process for producing optically active chromene derivative
AU2932700A (en) Process for preparing oxazole derivatives
AU2001262746A1 (en) Process for the preparation of optically active thiazolidinone derivatives
IL141607A0 (en) Microbial process for preparation of optically active 3-hydroxypyrolidine derivatives
AU2002234897A1 (en) Process for producing optically active n-aryl-1-amino-2-propanol derivatives
AU6554400A (en) Device for artificial stone production
AU2001261564A1 (en) Process for preparing cis-aminochromanols
AU2001292282A1 (en) Process for producing optically active 3-hydroxy-gamma-butyrolactone
AU2001244672A1 (en) Process for producing optically active 7-substituted-3-(2-aminopropyl)indole derivatives and intermediates for producing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase